About the authors

Kevin Jon Williams

KJ Williams is Professor of Medicine, Professor of Biochemistry and Molecular Biology, and a Member of the Center for Human Virology and Biodefense at Thomas Jefferson University, Philadelphia, PA, USA. His research on cardiovascular disease focuses on how normal arteries develop atherosclerosis, how this disorder might be stabilized or reversed, and novel mechanisms that control secretion and then clearance of plasma apolipoprotein B-containing lipoproteins. He is the sole or coinventor of about a dozen US patents to date. He was also instrumental in the recent conversion of computerized residency matches in North America from hospital-optimal to student-optimal algorithms.

Jonathan E Feig

JE Feig graduated summa cum laude with a BA degree in chemistry and was inducted into Phi Beta Kappa (Brooklyn College, Brooklyn, NY, USA). His passion for medicine and research led him to pursue a MD/PhD degree at the New York University School of Medicine, New York, NY. His thesis program, under the guidance of Edward A Fisher, involves studying the role of molecular factors in the regression of atherosclerosis.

Edward A Fisher

EA Fisher is the Leon H Charney Professor of Cardiovascular Medicine and Director of both the Marc and Ruti Bell Vascular Biology Program and the Center for the Prevention of Cardiovascular Disease, all at the New York University School of Medicine. His research focuses on atherosclerosis and lipoprotein metabolism. He is an Associate Editor of Arteriosclerosis, Thrombosis, and Vascular Biology (a publication of the AHA) and is on the editorial board of the Journal of Clinical Investigation. A recipient of the Solomon Berson Award for Basic Research Achievement from the New York University School of Medicine, he will be the George Eastman Visiting Professor at Oxford in 2010–2011.